Global Health Limited — Q4 FY26
Global Health (Medanta) reported a strong Q4 FY26 with revenue of ₹1,196 crore (+25% YoY) and PAT of ₹147 crore (+14% YoY), driven by robust volume growth (IPD +23%, OPD +27%) a...
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY26
NOIA losses expected to moderate
Management indicated that Q3 losses at NOIA are likely near peak and should reduce as the hospital ramps up.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1